Immuneering CorporationIMRXNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-45.49M
↓ 30% vs avg
Percentile
P33
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-34.97M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-45.49M | +17.4% |
| 2024 | $-55.08M | -11.7% |
| 2023 | $-49.31M | -10.0% |
| 2022 | $-44.84M | -45.1% |
| 2021 | $-30.91M | -110.7% |
| 2020 | $-14.67M | -228.8% |
| 2019 | $-4.46M | - |